RxDoctor Payments Data

Matko Kalac

Hematology & Oncology · Orange, CANPI 1720378763

Payments from drug & device makers

$780,484in general payments, 2019–2025

Across 145 payments — averaging $5382.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$680K
  • Otsuka Pharmaceutical Co., Ltd.$39K
  • Kyowa Kirin, Inc.$23K
  • Seagen Inc.$22K
  • Acrotech Biopharma Inc.$9K
  • Incyte Corporation$4K
  • plus $4K from 5 others

What the payments were for

  • Consulting fees$33,00353%
  • Speaking & faculty fees$15,44325%
  • Travel & lodging$11,08918%
  • Food & beverage$2,8175%
  • Education$120%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC64$679,719
Otsuka Pharmaceutical Co., Ltd.2$38,939
Kyowa Kirin, Inc.25$22,879
Seagen Inc.25$22,148
Acrotech Biopharma Inc.13$8,634
Incyte Corporation9$4,281
Gilead1$1,700
AstraZeneca3$1,434
Amgen1$424
Eurofins Viracor, LLC1$188
TG Therapeutics, Inc.1$137

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$780,484 in reported general payments places this provider in the 85th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →